During the past decade, Sundance Clinical Research, LLC conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 46 clinical trials were completed, i.e. on average, 79.3% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 29 clinical trials were completed. i.e. 78.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sundance Clinical Research, LLC" #1 sponsor was "Pfizer" with 20 trials, followed by "ModernaTX, Inc." with 6 trials sponsored, "Purdue Pharma LP" with 4 trials sponsored, "Seqirus" with 4 trials sponsored and "BioNTech SE" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sundance Clinical Research, LLC" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Sundance Clinical Research, LLC" are "COVID-19" (5 trials), "Influenza" (5 trials), "Osteoarthritis" (5 trials), "SARS-CoV-2 Infection" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Sundance Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Sundance Clinical Research, LLC" are "Biological" (42 trials), "Drug" (39 trials), "Other" (8 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Saline" (5 trials), "Rimegepant" (4 trials), "BNT162b2" (3 trials) and "Naproxen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sundance Clinical Research, LLC" are 84 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sundance Clinical Research, LLC". undefined are not yet recruiting, 3 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Sundance Clinical Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sundance Clinical Research, LLC, 6 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".